BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33661485)

  • 1. Evaluation of Barrier Functions in Human iPSC-Derived Intestinal Epithelium.
    Yamada S; Kanda Y
    Methods Mol Biol; 2021; 2367():27-35. PubMed ID: 33661485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoic acid promotes barrier functions in human iPSC-derived intestinal epithelial monolayers.
    Yamada S; Kanda Y
    J Pharmacol Sci; 2019 Aug; 140(4):337-344. PubMed ID: 31399314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Method for Two-Dimensional Epithelial Monolayer Formation Derived from Mouse Three-Dimensional Small Intestinal Organoids.
    Takase Y; Takahashi T
    Methods Mol Biol; 2024; 2749():73-84. PubMed ID: 38133775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional intestinal monolayers from organoids derived from human iPS cells for drug discovery research.
    Inui T; Uraya Y; Yokota J; Yamashita T; Kawai K; Okada K; Ueyama-Toba Y; Mizuguchi H
    Stem Cell Res Ther; 2024 Feb; 15(1):57. PubMed ID: 38424603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of metformin in the pro-inflammatory cytokine induced intestinal organoids injury model.
    Hahn S; Kim G; Jin SM; Kim JH
    Biochem Biophys Res Commun; 2024 Jan; 690():149291. PubMed ID: 38006803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient Generation of Cynomolgus Monkey Induced Pluripotent Stem Cell-Derived Intestinal Organoids with Pharmacokinetic Functions.
    Onozato D; Yamashita M; Fukuyama R; Akagawa T; Kida Y; Koeda A; Hashita T; Iwao T; Matsunaga T
    Stem Cells Dev; 2018 Aug; 27(15):1033-1045. PubMed ID: 29742964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Utilization of Human iPS Cells for Evaluation of Drug Disposition and Mucosal Damages in the Small Intestine].
    Iwao T
    Yakugaku Zasshi; 2023; 143(3):243-247. PubMed ID: 36858557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Physiologically Responsive Human iPSC-Derived Intestinal Epithelium to Study Barrier Dysfunction in IBD.
    Gleeson JP; Estrada HQ; Yamashita M; Svendsen CN; Targan SR; Barrett RJ
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief summary of the current protocols for generating intestinal organoids.
    Miura S; Suzuki A
    Dev Growth Differ; 2018 Aug; 60(6):387-392. PubMed ID: 30039581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of human induced pluripotent stem cell-derived intestinal organoids on colitis-model mice.
    Nakanishi A; Toyama S; Onozato D; Watanabe C; Hashita T; Iwao T; Matsunaga T
    Regen Ther; 2022 Dec; 21():351-361. PubMed ID: 36161099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal organoids: A new paradigm for engineering intestinal epithelium in vitro.
    Rahmani S; Breyner NM; Su HM; Verdu EF; Didar TF
    Biomaterials; 2019 Feb; 194():195-214. PubMed ID: 30612006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding disruption of the gut barrier during inflammation: Should we abandon traditional epithelial cell lines and switch to intestinal organoids?
    Lechuga S; Braga-Neto MB; Naydenov NG; Rieder F; Ivanov AI
    Front Immunol; 2023; 14():1108289. PubMed ID: 36875103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of Budding-Like Intestinal Organoids from Human Induced Pluripotent Stem Cells.
    Onozato D; Ogawa I; Kida Y; Mizuno S; Hashita T; Iwao T; Matsunaga T
    J Pharm Sci; 2021 Jul; 110(7):2637-2650. PubMed ID: 33794275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Microbiota and Intestinal Trans-Epithelial Permeability.
    Allam-Ndoul B; Castonguay-Paradis S; Veilleux A
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The JAK-Inhibitor Tofacitinib Rescues Human Intestinal Epithelial Cells and Colonoids from Cytokine-Induced Barrier Dysfunction.
    Sayoc-Becerra A; Krishnan M; Fan S; Jimenez J; Hernandez R; Gibson K; Preciado R; Butt G; McCole DF
    Inflamm Bowel Dis; 2020 Feb; 26(3):407-422. PubMed ID: 31751457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enteric Pathogens and Their Toxin-Induced Disruption of the Intestinal Barrier through Alteration of Tight Junctions in Chickens.
    Awad WA; Hess C; Hess M
    Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28208612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A permeability assay for mouse intestinal organoids.
    den Daas SA; Soffientini U; Chokshi S; Mehta G
    STAR Protoc; 2022 Jun; 3(2):101365. PubMed ID: 35542176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tight Junction Protein Claudin-7 Is Essential for Intestinal Epithelial Stem Cell Self-Renewal and Differentiation.
    Xing T; Benderman LJ; Sabu S; Parker J; Yang J; Lu Q; Ding L; Chen YH
    Cell Mol Gastroenterol Hepatol; 2020; 9(4):641-659. PubMed ID: 31874254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Micro- and Nano-Plastics on Human Intestinal Organoid-Derived Epithelium.
    Wang B; Iglesias-Ledon L; Bishop M; Chadha A; Rudolph SE; Longo BN; Cairns DM; Chen Y; Kaplan DL
    Curr Protoc; 2024 Apr; 4(4):e1027. PubMed ID: 38588063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of murine host sex as a biological variable in epithelial barrier function and muscle contractility in human intestinal organoids.
    Beanland BT; McNeill EP; Sequeira DJ; Xue H; Shroyer NF; Speer AL
    FASEB J; 2022 Nov; 36(11):e22613. PubMed ID: 36250916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.